Abstract: The present invention relates to the cosmetic or pharmaceutical use of an extract of a nonfruiting nonphotosynthetic filamentous bacterium in a composition containing a cosmetically or pharmaceutically acceptable medium, as an agent increasing the endogenous synthesis of superoxide dismutase, in particular for preventing and/or limiting the formation of free radicals and/or removing the free radicals present in cells; in addition, the invention relates to a composition comprising at least one extract of Vitreoscilla filiformis and lycopene.

Abstract: The present invention relates to the cosmetic or pharmaceutical use of an extract of a nonfruiting nonphotosynthetic filamentous bacterium in a composition containing a cosmetically or pharmaceutically acceptable medium, as an agent increasing the endogenous synthesis of superoxide dismutase, in particular for preventing and/or limiting the formation of free radicals and/or removing the free radicals present in cells; in addition, the invention relates to a composition comprising at least one extract of Vitreoscilla filiformis and lycopene.

Abstract: The present invention relates to the use of ginsenosides and a plant extract containing ginsenosides in a cosmetic or pharmaceutical composition or in a food supplement for the protection of the skin against deleterious effects of stress or irradiation e.g. sunlight or UV irradiation.

Abstract: Use of an extract of Griffonia, in particular of Griffonia simplicifolia, in a cosmetic or dermatological preparation for attenuating the pigmentation of the skin and of superficial body growths. This cosmetic or dermatological preparation may also contain any of the following products: at least one other active depigmenting product, at least one substance for filtering or blocking B and/or A ultraviolet radiation, at least one anti-inflammatory product, at least one agent encouraging flaking. It contains from 0.05 to 20% by weight of an extract of Griffonia simplicifolia.

Abstract: The present invention relates to the cosmetic or pharmaceutical use of an extract of a nonfruiting nonphotosynthetic filamentous bacterium in a composition containing a cosmetically or pharmaceutically acceptable medium, as an agent increasing the endogenous synthesis of superoxide dismutase, in particular for preventing and/or limiting the formation of free radicals and/or removing the free radicals present in cells; in addition, the invention relates to a composition comprising at least one extract of Vitreoscilla filiformis and lycopene.

Abstract: The present invention relates to the use of 3-O-acetyl-11-ketoboswellic acid, or of a plant extract or composition containing it, for topical application to the skin, as an agent to soften lines and/or relax the skin. The plant extract is in particular an extract of Boswellia serrata.

Abstract: The invention relates to the use of at least one protectin or protectin precursor production activator in a cosmetic composition or for preparing a composition intended to limit the side-effects of complement activation on the skin, mucosae and/or scalp. It also relates to compositions comprising such activators, to a method of selecting a product capable of protecting the cell membranes and a cosmetic method of enhancing the skin's resistance to the effects of complement activation.

Abstract: The present invention relates to the cosmetic or pharmaceutical use of an extract of a nonfruiting nonphotosynthetic filamentous bacterium in a composition containing a cosmetically or pharmaceutically acceptable medium, as an agent increasing the endogenous synthesis of superoxide dismutase, in particular for preventing and/or limiting the formation of free radicals and/or removing the free radicals present in cells; in addition, the invention relates to a composition comprising at least one extract of Vitreoscilla filiformis and lycopene.

Abstract: The present invention concerns a process for preparing an aqueous composition in the form of a gel at a given temperature. The process is characterized in that an associative water-soluble polymer constituted by a hydrophilic main chain and hydrophobic pendant groups is brought into the presence, in said composition, of at least one surfactant in the form of bilayers when it is in aqueous solution under the same temperature and concentration conditions. Compositions in the form of gels or liquids are thus obtained.

Abstract: The present invention concerns a process for preparing an aqueous composition in the form of a gel at a given temperature.

Abstract: The invention concerns novel uses in cosmetics or pharmaceutics, in particular in dermatology, of Rb1 ginsenoside(G-Rb1) and plant extracts containing same, to stimulate elastin synthesis by dermal fibroblasts. The invention also concerns cosmetic or pharmaceutical, in particular dermatological, compositions containing said ginsenoside or plant extracts for stimulating the elastin synthesis by dermal fibroblasts. Said compositions advantageously contain an extract of Asiatic ginseng or of American ginseng.

Abstract: The present invention concerns a process for preparing an aqueous composition in the form of a gel at a given temperature. The process is characterized in that an associative water-soluble polymer constituted by a hydrophilic main chain and hydrophobic pendant groups is brought into the presence, in said composition, of at least one surfactant in the form of bilayers when it is in aqueous solution under the same temperature and concentration conditions. Compositions in the form of gels or liquids are thus obtained.

Abstract: The invention relates to novel microgel-containing essentially organic solvent nail varnishes. The microgels are particularly acrylic microgels. The invention also relates to the use of these microgels for modifying the physical properties of an essentially organic solvent nail varnish composition, and/or the properties of the film obtained during the application of said composition.

Abstract: The invention relates to the use of an extract of the plant Potentilla erecta in the field of cosmetics and pharmacy, especially in dermatology. The invention more particularly relates to any application in which it is sought to reinforce the dermo-epidermal junction or to improve hair condition, by the improvement of the synthesis of collagen VII by keratinocytes and/or fibroblasts. In particular, these applications concern toning of the skin, diminishing of wrinkles or hair care. The invention also relates to a novel method of culture of cells, in particular of human fibroblasts or keratinocytes, for promoting the formation of collagen VII.

Abstract: The invention relates to a chain end functionalised polymer of formula: ##STR1## in which: the polymer chain (P) is a hydrophobic chain obtained by radical polymerisation of at least one monomer,R represents a hydrogen atom or a linear or branched hydrocarbon chain having 1 to 8 carbon atoms optionally substituted with at least one group selected from CO.sub.2, NH.sub.2, OH or a phenyl group, itself being optionally substituted,A and B, identical or different, each represent a single bond, a saturated or unsaturated linear or branched hydrocarbon chain having from 1 to 16 carbon atoms, it being possible for it to contain an amide bond or a peptide chain having 2 to 4 amino acids, particularly natural amino acids,the NH.sub.2 and/or COOH groups being free or salified.The invention also relates to the use of the above products as surfactants and more particularly as wetting agents, dispersing agents of solid particles and for preparing microdispersions of polymers, in particular microgels and microlatexes.

Abstract: The present invention relates to the use of an .alpha.-tocopherol phosphate, especially in its dl or d form, or an ester thereof, of the general formula ##STR1## in which: R.sub.1 is a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, such as the methyl or ethyl radical in particular, or an .alpha.-tocopheryl radical; and R.sub.2 is a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, such as methyl or ethyl radical in particular, or an oxyethylene chain of the formula ##STR2## in which R.sub.3 and R.sub.4 independently are a hydrogen atom or a methyl radical and n is an integer greater than or equal to 1, or a salt thereof, for preparing a pharmaceutical, dermatological or cosmetic composition for the prevention or treatment of allergic manifestations such as skin allergy or bronchial asthma, or inflammatory manifestations, or for the prevention or treatment of the harmful effects of free radicals.

Abstract: The invention relates to a functionalised polymer of formula:(P)--S--X--F (1)in which:(P) is a hydrophobic polymer chain obtained by radical polymerisation of at least one monomer,S represents sulphur,X represents:a saturated or unsaturated linear or branched hydrocarbon chain having 1 to 6 carbon atoms and substituted with at least one COOH or NH.sub.2 group in the free or salified forma peptide chain constituted of 2 to 4 amino acids, particularly natural amino acids,F represents a COOH or NH.sub.2 group, in the free or salified form,with the exception of the .omega.-dicarboxylic macromonomers resulting from the radical polymerisation of a monomer in the presence of a chain transfer agent constituted of thiomalic acid.

Abstract: The present invention relates to a novel composition based on hydrated lipidic lamellar phase or on liposomes and to a cosmetic or pharmaceutical, particularly dermatological composition incorporating it. The hydrated lipidic lamellar phases or the liposomes contain at least in part a derivative of labdane, or a plant extract containing it. The invention reduces hair loss and promotes hair growth.

Abstract: The present invention relates to solid complex particles, each comprised of at least two solid substances, at least one of them being biologically active.The biologically active solid substance is comprised of at least one biologically active product and is evenly distributed at the surface of a grain consisting of the other solid core-forming substance, so-called support substance, said grain having a size comprised between 0.05 and 100 .mu.m (microns) and the weight ratio between said active substance and said core-forming substance being comprised between 10.sup.-4 and 1.5 approximately.The invention also relates to a method for the preparation of said particles, a process for the treatment of a biological surface in order to accelerate the biodisponibility of a biologically active substance.It also relates to compositions for topical application containing the particles of the invention.

Abstract: The invention relates to the use of ascorbic acid, notably L-ascorbic acid or vitamin C, or of its erythorbic acid isomer, or of their salts or esters, for promoting the synthesis of elastin in the dermis in the view of improving in particular skin elasticity.The invention enables manufacturing cosmetic or pharmaceutical compositions, notably dermatological compositions, for improving skin elasticity, for example in the context of a product which improves skin tone or skin firmness.The invention also enables increasing the elastin content of artificial dermes.